← Open Payments lookup

JULIETTE FOLSE: Open Payments

NPI 1902588759 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,871 in 31 payments from 12 companies in 2025. Trend: 2023 $371 · 2024 $1,286 · 2025 $1,871

Food & beverage: $1,791Education: $80
CompanyPaymentsAmount
Astellas Pharma US Inc8$477
Incyte Corporation4$291
Takeda Pharmaceuticals U.S.A., Inc.4$220
SANOFI-AVENTIS U.S. LLC3$216
Syndax Pharmaceuticals, Inc.2$155
ABBVIE INC.1$125
JAZZ PHARMACEUTICALS INC.1$107
GlaxoSmithKline, LLC.2$105
Janssen Biotech, Inc.2$64
Gamida Cell Inc.2$48

Products named: LIVTENCITY, REZUROCK, Cresemba, Xospata, Jakafi, NIKTIMVO, RYLAZE, OJJAARA.

Industry payments across TX — which companies pay providers there.